| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06510
The bovine papillomavirus E2 protein can inhibit the proliferation of HT-3 cells, a p53-negative cervical carcinoma cell line containing integrated human papillomavirus type 30 DNA. Here, we analyzed HT-3 cells to explore the mechanism of p53-independent E2-mediated growth inhibition. Expression of the E2 protein repressed expression of the endogenous human papillomavirus type 30 E6/E7 genes. This was accompanied by hypophosphorylation and increased accumulation of p105Rb and repression of E2F1 expression. The E2 protein also caused reduced cyclin-dependent kinase (cdk) 2 activity, but this did not appear to be due to increased expression of cdk inhibitors. Rather, expression of cyclin A, which regulates cdk2 activity, and the cdc25A and cdc25B phosphatases, which are thought to activate cdk2, was significantly reduced at both the RNA and protein levels in response to E2 expression. The E2 protein reduced expression of cdc25A and cdc25B in both HT-3 and HeLa cells, but not in cells that were not growth-inhibited by the E2 protein. E2 point mutants unable to inhibit cell growth did not repress cdc25A and cdc25B expression, nor did the cell cycle inhibitors hydroxyurea and mimosine. Based on these results and the known properties of cell cycle components, we propose a model to account for E2-induced growth inhibition of cervical carcinoma cell lines.
This article has been cited by other articles:
![]() |
E. C. Goodwin, W. J. Atwood, and D. DiMaio High-Throughput Cell-Based Screen for Chemicals That Inhibit Infection by Simian Virus 40 and Human Polyomaviruses J. Virol., June 1, 2009; 83(11): 5630 - 5639. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Nguyen, R. M. Kraft, M. Aubert, E. Goodwin, D. DiMaio, and J. A. Blaho p53 and hTERT Determine Sensitivity to Viral Apoptosis J. Virol., December 1, 2007; 81(23): 12985 - 12995. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Johung, E. C. Goodwin, and D. DiMaio Human Papillomavirus E7 Repression in Cervical Carcinoma Cells Initiates a Transcriptional Cascade Driven by the Retinoblastoma Family, Resulting in Senescence J. Virol., March 1, 2007; 81(5): 2102 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wollmann, P. Tattersall, and A. N. van den Pol Targeting Human Glioblastoma Cells: Comparison of Nine Viruses with Oncolytic Potential J. Virol., May 15, 2005; 79(10): 6005 - 6022. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Psyrri, R. A. DeFilippis, A. P. B. Edwards, K. E. Yates, L. Manuelidis, and D. DiMaio Role of the Retinoblastoma Pathway in Senescence Triggered by Repression of the Human Papillomavirus E7 Protein in Cervical Carcinoma Cells Cancer Res., May 1, 2004; 64(9): 3079 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Horner, R. A. DeFilippis, L. Manuelidis, and D. DiMaio Repression of the Human Papillomavirus E6 Gene Initiates p53-Dependent, Telomerase-Independent Senescence and Apoptosis in HeLa Cervical Carcinoma Cells J. Virol., April 15, 2004; 78(8): 4063 - 4073. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Thierry, M. A. Benotmane, C. Demeret, M. Mori, S. Teissier, and C. Desaintes A Genomic Approach Reveals a Novel Mitotic Pathway in Papillomavirus Carcinogenesis Cancer Res., February 1, 2004; 64(3): 895 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. U. Barbie, D. A. Barbie, D. T. MacLaughlin, S. Maheswaran, and P. K. Donahoe Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107 PNAS, December 23, 2003; 100(26): 15601 - 15606. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. DeFilippis, E. C. Goodwin, L. Wu, and D. DiMaio Endogenous Human Papillomavirus E6 and E7 Proteins Differentially Regulate Proliferation, Senescence, and Apoptosis in HeLa Cervical Carcinoma Cells J. Virol., December 20, 2002; 77(2): 1551 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Talora, D. C. Sgroi, C. P. Crum, and G. P. Dotto Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation Genes & Dev., September 1, 2002; 16(17): 2252 - 2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Dick and N. J. Dyson Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins J. Virol., May 13, 2002; 76(12): 6224 - 6234. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Goodwin and D. DiMaio Induced Senescence in HeLa Cervical Carcinoma Cells Containing Elevated Telomerase Activity and Extended Telomeres Cell Growth Differ., November 1, 2001; 12(11): 525 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Goodwin and D. DiMaio Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways PNAS, November 7, 2000; 97(23): 12513 - 12518. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu, E. C. Goodwin, L. K. Naeger, E. Vigo, K. Galaktionov, K. Helin, and D. DiMaio E2F-Rb Complexes Assemble and Inhibit cdc25A Transcription in Cervical Carcinoma Cells following Repression of Human Papillomavirus Oncogene Expression Mol. Cell. Biol., October 1, 2000; 20(19): 7059 - 7067. [Abstract] [Full Text] |
||||
![]() |
E. C. Goodwin, E. Yang, C.-J. Lee, H.-W. Lee, D. DiMaio, and E.-S. Hwang Rapid induction of senescence in human cervical carcinoma cells PNAS, September 26, 2000; 97(20): 10978 - 10983. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Dick, E. Sailhamer, and N. J. Dyson Mutagenesis of the pRB Pocket Reveals that Cell Cycle Arrest Functions Are Separable from Binding to Viral Oncoproteins Mol. Cell. Biol., May 15, 2000; 20(10): 3715 - 3727. [Abstract] [Full Text] |
||||
![]() |
P. Ogston, K. Raj, and P. Beard Productive Replication of Adeno-Associated Virus Can Occur in Human Papillomavirus Type 16 (HPV-16) Episome-Containing Keratinocytes and Is Augmented by the HPV-16 E2 Protein J. Virol., April 15, 2000; 74(8): 3494 - 3504. [Abstract] [Full Text] |
||||
![]() |
D. A. Francis, S. I. Schmid, and P. M. Howley Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells J. Virol., March 15, 2000; 74(6): 2679 - 2686. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |